- Home
- TBHC vs SCLX Comparison
TBHC vs SCLX Comparison
Compare TBHC & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBHC
- SCLX
- Stock Information
- Founded
- TBHC 1966
- SCLX 2011
- Country
- TBHC United States
- SCLX United States
- Employees
- TBHC N/A
- SCLX N/A
- Industry
- TBHC Other Specialty Stores
- SCLX Biotechnology: Pharmaceutical Preparations
- Sector
- TBHC Consumer Discretionary
- SCLX Health Care
- Exchange
- TBHC Nasdaq
- SCLX Nasdaq
- Market Cap
- TBHC 40.4M
- SCLX 35.7M
- IPO Year
- TBHC N/A
- SCLX N/A
- Fundamental
- Price
- TBHC $1.57
- SCLX $18.18
- Analyst Decision
- TBHC
- SCLX Buy
- Analyst Count
- TBHC 0
- SCLX 2
- Target Price
- TBHC N/A
- SCLX $245.00
- AVG Volume (30 Days)
- TBHC 152.1K
- SCLX 248.9K
- Earning Date
- TBHC 12-05-2025
- SCLX 08-13-2025
- Dividend Yield
- TBHC N/A
- SCLX N/A
- EPS Growth
- TBHC N/A
- SCLX N/A
- EPS
- TBHC N/A
- SCLX N/A
- Revenue
- TBHC $420,610,000.00
- SCLX $44,236,000.00
- Revenue This Year
- TBHC N/A
- SCLX $89.26
- Revenue Next Year
- TBHC N/A
- SCLX $203.95
- P/E Ratio
- TBHC N/A
- SCLX N/A
- Revenue Growth
- TBHC N/A
- SCLX N/A
- 52 Week Low
- TBHC $1.20
- SCLX $3.60
- 52 Week High
- TBHC $2.40
- SCLX $39.90
- Technical
- Relative Strength Index (RSI)
- TBHC 45.96
- SCLX 52.53
- Support Level
- TBHC $1.52
- SCLX $13.08
- Resistance Level
- TBHC $1.80
- SCLX $14.74
- Average True Range (ATR)
- TBHC 0.12
- SCLX 1.56
- MACD
- TBHC 0.00
- SCLX 0.45
- Stochastic Oscillator
- TBHC 34.29
- SCLX 75.14
About TBHC The Brand House Collective Inc.
The Brand House Collective Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.